Palumbo A et al: Autologous transplantation and maintenance therapy in multiple myeloma. N Engl J Med 371: 895-905, 2014
Gay F et al: Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial. Lancet Oncol 16: 1617-1629, 2015
Cavo M et al: Upfront autologous stem cell transplantation (ASCT) versus novel agent-based therapy for multiple myeloma (MM): A randomized phase 3 study of the European Myeloma Network (EMN02/HO95 MM trial) . ASCO Meeting Abstracts 34: 8000, 2016